Literature DB >> 16723239

A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity.

Takashi Ohtsuka1, Ken-Ichi Watanabe, Masahiro Kaji, Tsuguo Naruke, Keiichi Suemasu.   

Abstract

OBJECTIVE: Pulmonary lesions with focal ground-glass opacity (GGO) have been detected increasingly by low-dose helical computed tomography (CT). However, the strategy of treatment for focal pure GGO lesions is still undecided. This study evaluates clinicopathological characteristics of resected pulmonary nodules with focal pure ground-glass opacity.
METHODS: Between January 1997 and December 2005, 26 patients (35 lesions) with pure GGO lesions underwent pulmonary resection. The data on patient age, lesion size, pathology, carcinoembryonic antigen (CEA) level and palpability of the tumor in the resected specimen were evaluated.
RESULTS: The histological diagnosis was bronchioloalveolar carcinoma (BAC) in 10 patients (12 lesions), atypical adenomatous hyperplasia (AAH) in 15 patients (22 lesions), and focal scar in 1 patient (1 lesion). There were no significant differences in age, sex, tumor size, and CEA level between the patients with BAC, AAH, and focal scar. However, the lesions >10mm in size were all BAC. Palpability of the tumor in the resected specimen was significantly more frequent in BAC cases than in AAH cases (p<0.01). For BAC, lobectomy was performed for four lesions, and limited resection for eight. None of the BACs showed lymphatic or vascular invasion upon pathological examination. At the median follow-up point of 44 months (range: 4-84 months), no recurrences were observed.
CONCLUSIONS: BAC and AAH cannot be discriminated by their size. In the resected specimen, BAC lesions are more frequently palpable than AAH lesions. Thoracoscopic surgery is recommended for focal pure GGO after repeated CT even if the GGO lesion is small. Partial resection is a sufficient treatment for pure GGO.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723239     DOI: 10.1016/j.ejcts.2006.03.058

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  18 in total

1.  Multidetector CT features of pulmonary focal ground-glass opacity: differences between benign and malignant.

Authors:  L Fan; S-Y Liu; Q-C Li; H Yu; X-S Xiao
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

2.  Short- and long-term lung cancer risk associated with noncalcified nodules observed on low-dose CT.

Authors:  Paul F Pinsky; P Hrudaya Nath; David S Gierada; Sushil Sonavane; Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-22

3.  Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules.

Authors:  Giulia Veronesi; Eva Szabo; Andrea Decensi; Aliana Guerrieri-Gonzaga; Massimo Bellomi; Davide Radice; Stefania Ferretti; Giuseppe Pelosi; Matteo Lazzeroni; Davide Serrano; Scott M Lippman; Lorenzo Spaggiari; Angela Nardi-Pantoli; Sergio Harari; Clara Varricchio; Bernardo Bonanni
Journal:  Cancer Prev Res (Phila)       Date:  2010-12-16

Review 4.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

5.  Accuracy of CT parameters for assessment of tumour size and aggressiveness in lung adenocarcinoma with bronchoalveolar elements.

Authors:  U N Bhure; D Lardinois; V Kalff; T F Hany; A Soltermann; B Seifert; H C Steinert
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

6.  Surgery for undiagnosed ground glass pulmonary nodules: decision making using serial computed tomography.

Authors:  Kazuhiro Ueda; Masataro Hayashi; Nobuyuki Tanaka; Yoshinobu Hoshii; Toshiki Tanaka; Kimikazu Hamano
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

7.  Outcomes: wedge resection versus lobectomy for non-small cell lung cancer at the Cancer Centre of Southeastern Ontario 1998-2009.

Authors:  Anna L McGuire; Wilma M Hopman; Dimitri Petsikas; Ken Reid
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

8.  Malignant pure pulmonary ground-glass opacity nodules: prognostic implications.

Authors:  Jong Heon Park; Kyung Soo Lee; Ji Hye Kim; Young Mog Shim; Jhingook Kim; Yong Soo Choi; Chin A Yi
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

Review 9.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Michael K Gould; Jessica Donington; William R Lynch; Peter J Mazzone; David E Midthun; David P Naidich; Renda Soylemez Wiener
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 10.  Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Eva Szabo; Jenny T Mao; Stephen Lam; Mary E Reid; Robert L Keith
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.